Active Ingredient(s): Mitoxantrone
FDA Approved: * December 23, 1987
Pharm Company: * SERONO INC
Category: Cancer

Mitoxantrone (INN, BAN, USAN; also known as Mitozantrone in Australia; trade name Novantrone) is an anthracenedione antineoplastic agent. Contents 1 Uses 2 Side effects 3 Mechanism of action 4 See also 5 References 6 External links Uses Mitoxantrone is used to treat certain types of cancer, mostly acute myeloid leukemia. It improves the survival rate of children suffering from acute lymphoblastic leukemia relapse.[1] The combination of mitoxantrone and prednisone is app... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.